Microbot Medical

Microbot Medical company information, Employees & Contact Information

Explore related pages

Related company profiles:

Microbot Medical’s vision is to improve the quality of life of millions of patients globally by advancing robotic technologies to perform surgical procedures within the human body, and offer physicians and their patients less invasive and more precise solutions. The company’s innovations tap into one of the fastest-growing spaces in the medical field, the minimal invasive space. Microbot Medical develops robotic medical devices that provide doctors and surgeons with new technological capabilities to improve a patient’s health, comfort and quality of life. Microbot’s current technological platforms, LIBERTY® Robotic System, one&done™ ViRob™ and TipCAT™, are comprised of highly advanced technologies from which the Company is currently developing. To learn more about Microbot Medical, visit www.microbotmedical.com.. To learn more about Microbot Medical, visit www.microbotmedical.com.

Company Details

Employees
35
Founded
-
Address
6 Hayozma St, Yoqneam,israel 2069204,israel
Phone
97248200710
Email
in****@****cal.com
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
Keywords
micro-robotics.
HQ
Yoqneam, Israel
Looking for a particular Microbot Medical employee's phone or email?

Microbot Medical Questions

News

Microbot Medical® Secures U.S. Based Logistics Partner to - GlobeNewswire

Microbot Medical® Secures U.S. Based Logistics Partner to GlobeNewswire

Robotic Surgery Breakthrough: Microbot Medical's LIBERTY System Wins Japan Patent, Eyes 2.5M US Procedures - Stock Titan

Robotic Surgery Breakthrough: Microbot Medical's LIBERTY System Wins Japan Patent, Eyes 2.5M US Procedures Stock Titan

Microbot Medical® to Open Inaugural Endovascular Robotics Session at the Society of Robotic Surgery Annual Meeting - Yahoo Finance

Microbot Medical® to Open Inaugural Endovascular Robotics Session at the Society of Robotic Surgery Annual Meeting Yahoo Finance

Microbot Medical® Receives First Patent in Japan as it Continues to Broaden its Global Intellectual Property Portfolio - The Globe and Mail

Microbot Medical® Receives First Patent in Japan as it Continues to Broaden its Global Intellectual Property Portfolio The Globe and Mail

Microbot Medical Announces Final Closing of Exercise of - GlobeNewswire

Microbot Medical Announces Final Closing of Exercise of GlobeNewswire

First-Ever Single-Use Endovascular Robot: Microbot Medical's LIBERTY System Secures FDA Clearance - Stock Titan

First-Ever Single-Use Endovascular Robot: Microbot Medical's LIBERTY System Secures FDA Clearance Stock Titan

Microbot Medical® to Commercially Debut the LIBERTY® System - GlobeNewswire

Microbot Medical® to Commercially Debut the LIBERTY® System GlobeNewswire

100% Success Rate: Microbot Medical's Revolutionary LIBERTY Robot Cleared by FDA for Vascular Procedures - Stock Titan

100% Success Rate: Microbot Medical's Revolutionary LIBERTY Robot Cleared by FDA for Vascular Procedures Stock Titan

Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System - GlobeNewswire

Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System GlobeNewswire

Miocrbot Medical® CEO to Discuss Recent FDA Clearance of the LIBERTY® Endovascular Robotic System - GlobeNewswire

Miocrbot Medical® CEO to Discuss Recent FDA Clearance of the LIBERTY® Endovascular Robotic System GlobeNewswire

Microbot Medical® Receives Non-Dilutive Grant to Enhance Operational Capabilities - GlobeNewswire

Microbot Medical® Receives Non-Dilutive Grant to Enhance Operational Capabilities GlobeNewswire

Microbot Medical® Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales - GlobeNewswire

Microbot Medical® Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales GlobeNewswire

Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications - GlobeNewswire

Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications GlobeNewswire

Microbot Medical Continues to Strengthen Commercial Capabilities in Preparation for the anticipated Q3 2025 Launch of its LIBERTY® Endovascular Robotic System - GlobeNewswire

Microbot Medical Continues to Strengthen Commercial Capabilities in Preparation for the anticipated Q3 2025 Launch of its LIBERTY® Endovascular Robotic System GlobeNewswire

Microbot Medical® Added to the Russell Microcap® Index - GlobeNewswire

Microbot Medical® Added to the Russell Microcap® Index GlobeNewswire

Microbot Medical Selected for Preliminary Inclusion to Russell Microcap® Index - GlobeNewswire

Microbot Medical Selected for Preliminary Inclusion to Russell Microcap® Index GlobeNewswire

Microbot Medical® Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTY® - Yahoo Finance

Microbot Medical® Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTY® Yahoo Finance

Microbot Medical Announces $7 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules - GlobeNewswire

Microbot Medical Announces $7 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules GlobeNewswire

FDA Grants 510(k) Clearance for Microbot Medical's Endovascular Robotic System - Diagnostic and Interventional Cardiology

FDA Grants 510(k) Clearance for Microbot Medical's Endovascular Robotic System Diagnostic and Interventional Cardiology

Microbot Medical Inc. CEO to Discuss LIBERTY® Endovascular Robotic System FDA Clearance on Benzinga All Access - Quiver Quantitative

Microbot Medical Inc. CEO to Discuss LIBERTY® Endovascular Robotic System FDA Clearance on Benzinga All Access Quiver Quantitative

Microbot Medical Inc. Secures NIS 2.15 Million Grant from Israel Innovation Authority to Enhance LIBERTY® System Commercialization Efforts - Quiver Quantitative

Microbot Medical Inc. Secures NIS 2.15 Million Grant from Israel Innovation Authority to Enhance LIBERTY® System Commercialization Efforts Quiver Quantitative

Up to $92.2M: Microbot Medical completes final closing of preferred options; $29.2M raised to date - Stock Titan

Up to $92.2M: Microbot Medical completes final closing of preferred options; $29.2M raised to date Stock Titan

$92.2M Potential Funding: Microbot Medical Announces Major Investment Options Exercise for LIBERTY Robot - Stock Titan

$92.2M Potential Funding: Microbot Medical Announces Major Investment Options Exercise for LIBERTY Robot Stock Titan

Microbot Medical Lands Strategic $630K Grant as Revolutionary Endovascular Robot Awaits FDA Clearance - Stock Titan

Microbot Medical Lands Strategic $630K Grant as Revolutionary Endovascular Robot Awaits FDA Clearance Stock Titan

From 2.5M to 6M Procedures: Microbot Medical's New Patent Could Triple LIBERTY® Robot's Market Reach - Stock Titan

From 2.5M to 6M Procedures: Microbot Medical's New Patent Could Triple LIBERTY® Robot's Market Reach Stock Titan

Microbot Medical® Shares Results from Its Pivotal Clinical - GlobeNewswire

Microbot Medical® Shares Results from Its Pivotal Clinical GlobeNewswire

Microbot Medical Reveals FDA Timeline, Expands Commercial Team for Q3 2025 LIBERTY System Launch - Stock Titan

Microbot Medical Reveals FDA Timeline, Expands Commercial Team for Q3 2025 LIBERTY System Launch Stock Titan

LIBERTY Robotic Surgical System Achieved Additional Milestone in its Path to First in Human and Regulatory Process - FinancialContent

LIBERTY Robotic Surgical System Achieved Additional Milestone in its Path to First in Human and Regulatory Process FinancialContent

Microbot Medical Announces Strategic Collaboration with - GlobeNewswire

Microbot Medical Announces Strategic Collaboration with GlobeNewswire

Microbot Medical Announces Successful Animal Study Utilizing Its LIBERTY™ Robotic System - GlobeNewswire

Microbot Medical Announces Successful Animal Study Utilizing Its LIBERTY™ Robotic System GlobeNewswire

Top Microbot Medical Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant